Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk.
Saved in:
| Title: | Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. |
|---|---|
| Authors: | Chapman MJ; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr, Redfern JS, McGovern ME, Giral P |
| Source: | Pharmacology & therapeutics [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. Date of Electronic Publication: 2010 Feb 11. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Pergamon Press Country of Publication: England NLM ID: 7905840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-016X (Electronic) Linking ISSN: 01637258 NLM ISO Abbreviation: Pharmacol Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20153365 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chapman+MJ%22">Chapman MJ</searchLink>; Dyslipidemia, Inflammation and Atherosclerosis Research Unit, UMR-S939, National Institute for Health and Medical Research (INSERM), Hôpital de la Pitié-Salpetriere, Paris, France. john.chapman@upmc.fr<br /><searchLink fieldCode="AU" term="%22Redfern+JS%22">Redfern JS</searchLink><br /><searchLink fieldCode="AU" term="%22McGovern+ME%22">McGovern ME</searchLink><br /><searchLink fieldCode="AU" term="%22Giral+P%22">Giral P</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%227905840%22">Pharmacology & therapeutics</searchLink> [Pharmacol Ther] 2010 Jun; Vol. 126 (3), pp. 314-45. <i>Date of Electronic Publication: </i>2010 Feb 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Pergamon+Press%22">Pergamon Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>7905840 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-016X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201637258%22">01637258 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacol Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20153365 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.pharmthera.2010.01.008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 314 Titles: – TitleFull: Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chapman MJ – PersonEntity: Name: NameFull: Redfern JS – PersonEntity: Name: NameFull: McGovern ME – PersonEntity: Name: NameFull: Giral P IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2010 Jun Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1879-016X Numbering: – Type: volume Value: 126 – Type: issue Value: 3 Titles: – TitleFull: Pharmacology & therapeutics Type: main |
| ResultId | 1 |